Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide images.

Journal: Cell reports. Medicine
Published Date:

Abstract

Homologous recombination DNA-repair deficiency (HRD) is becoming a well-recognized marker of platinum salt and polyADP-ribose polymerase inhibitor chemotherapies in ovarian and breast cancers. While large-scale screening for HRD using genomic markers is logistically and economically challenging, stained tissue slides are routinely acquired in clinical practice. With the objectives of providing a robust deep-learning method for HRD prediction from tissue slides and identifying related morphological phenotypes, we first show that digital pathology workflows are sensitive to potential biases in the training set, then we propose a method to overcome the influence of these biases, and we develop an interpretation method capable of identifying complex phenotypes. Application to our carefully curated in-house dataset allows us to predict HRD with high accuracy (area under the receiver-operator characteristics curve 0.86) and to identify morphological phenotypes related to HRD. In particular, the presence of laminated fibrosis and clear tumor cells associated with HRD open new hypotheses regarding its phenotypic impact.

Authors

  • Tristan Lazard
    Center for Computational Biology (CBIO), Mines Paris, PSL University, 60 Boulevard Saint Michel, 75006 Paris, France; Institut Curie, PSL University, 75005 Paris, France; INSERM U900, 75005 Paris, France.
  • Guillaume Bataillon
    Pathologie, institut Curie, 26, r Ulm, 75005 Paris, France.
  • Peter Naylor
  • Tatiana Popova
    INSERM U830, DNA Repair and Uveal Melanoma (DRUM), Equipe Labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 75005 Paris, France.
  • François-Clément Bidard
    Department of Medical Oncology, Institut Curie Hospital, Paris, France; INSERM CIC-BT 1428, UVSQ, Paris-Saclay University, Saint-Cloud, France.
  • Dominique Stoppa-Lyonnet
    INSERM U830, DNA Repair and Uveal Melanoma (DRUM), Equipe Labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 75005 Paris, France; Université Paris Cité, 75006 Paris, France.
  • Marc-Henri Stern
    Diagnostic and Theranostic Medicine Division, Institut Curie, PSL University, Paris, France; INSERM U830, DNA Repair and Uveal Melanoma (DRUM), Equipe Labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, 75005 Paris, France.
  • Etienne Decencière
    Center for Mathematical Morphology (CMM), Mines Paris, PSL University, 77300 Fontainebleau, France.
  • Thomas Walter
  • Anne Vincent-Salomon
    Department of Diagnostic and Theranostic Medecine, Institut Curie Hospital, Paris, France.